MiNK Therapeutics Inc

Research MiNK Therapeutics Inc (INKT) on Bullrun: market cap USD 59.33M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerINKT
• ExchangeNASDAQ
• CountryUnited States
• SectorHealthcare
• IndustryBiotechnology
• CurrencyUSD
• Market capUSD 59.33M
• Financial periodFY2025
• Net income-USD 12.49M

Valuation Snapshot

latest market cap is USD 59.33M.

About MiNK Therapeutics Inc

MiNK Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, manufacture, and commercialization of allogeneic, off-the-shelf, and invariant natural killer T (iNKT) cell therapies to treat cancer and other immune-mediated diseases.

Frequently asked questions

What is MiNK Therapeutics Inc's market cap?

MiNK Therapeutics Inc's market capitalization is USD 59.33M.

What does MiNK Therapeutics Inc do?

MiNK Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, manufacture, and commercialization of allogeneic, off-the-shelf, and invariant natural killer T (iNKT) cell therapies to treat cancer and other immune-mediated diseases.